TX-SOFTSERVE
2.12.2021 13:07:03 CET | Business Wire | Press release
SoftServe , a leading digital authority and consulting company, has released its second bi-annual Sustainability Report . The report, prepared according to GRI Standards, highlights progress made against the company’s ongoing commitment to a sustainable business strategy, featuring key initiatives and achievements that positively impact society and the environment.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20211202005018/en/
“As a global organization, we must take responsibility towards our associates, customers, and communities,” said Chris Baker, CEO at SoftServe. “SoftServe is a people-centric company, focused on creating an inclusive workplace that supports our associates’ well-being, access to education, and innovation, which enables us to support sustainable development in our communities around the world.”
“In 2020 the world faced extraordinary new challenges that impacted each of us as individuals, and as a business,” said Taras Vervega, co-founder and board member at SoftServe. “It was another moment that revealed who we are as a company. The way SoftServe responded to the pandemic, the numerous solutions we have created to help our clients, and the massive response of our company and our people to help hospitals and local communities – all make me very proud of the company we’ve built.”
Diversity, Equality, and Inclusion
Since 2018, SoftServe has made significant progress towards gender equality, as the rate of women in managerial roles grew from 35% in 2018 to 49% in 2020. Additionally, as part of its inclusivity efforts, in 2020 the company launched its first learning course in accessibility testing for visually impaired people , and its graduates are now part of SoftServe’s accessibility testing team.
Advancing IT Education
Developing IT education is another focus of the company’s social initiatives. SoftServe’s IT Academy , an educational platform for students and graduates, enrolled 2,759 students and subsequently hired 1,368 graduates upon completion of its programs over the last two years. SoftServe currently maintains partnerships with 34 universities and tech schools in Ukraine, Bulgaria, and Poland, establishing new IT bachelor’s degree programs, launching tech labs, and hosting numerous educational events.
Empowering Communities
SoftServe’s approach to social responsibility includes empowering its people to give back to their communities. In 2020 SoftServe became strategic partner to UNICEF Ukraine. The parties cooperated on educational programs and initiatives in Ukraine to exchange knowledge and professional experience and worked together on several pro bono technology solutions.
Throughout 2020, SoftServe built a framework to engage associates in pro bono projects that address pressing social issues and created the company’s Open Tech crowdsourcing platform. Together with NGOs and governmental institutions, SoftServe contributed to a number of projects, including Ukraine’s National Volunteer Platform , created with UNICEF Ukraine, the Ukrainian Volunteer Service, and the Ministry of Youth and Sports of Ukraine. The Platform is an online portal that helps connect volunteers with opportunities around social assistance, education and science, culture, art, and more.
SoftServe also developed a COVID-19 triage chatbot for the Bulgarian government to provide citizens with critical information, answers to frequently asked questions, and healthcare contact information to help assess symptoms and navigate the next steps. Using advanced conversational AI, the triage chatbot quickly assesses users with a series of text or voice questions, eliminating staff burden and soothing patient fears. It is an omnichannel communication tool available on any smartphone, computer, or tablet, and can help to triage patients in under 30 seconds.
Other key social achievements include:
- 4 international awards for SoftServe’s corporate social responsibility and sustainability initiatives and projects
- 92 volunteer and charitable projects accomplished in 2019–2020
- 50+ events launched dedicated to emotional health and employee well-being
- 752 computers donated to educational establishments in 2019-2020
- 10,000+ trees planted in 2019–2020
- $882,500 contributed to projects implemented by SoftServe’s “Open Eyes” charity fund in 2019–2020
- 10+ tons of medical equipment funded via SoftServe & “Open Eyes” charity fund
About SoftServe
SoftServe is a digital authority that advises and provides at the cutting-edge of technology. We reveal, transform, accelerate, and optimize the way enterprises and software companies do business. With expertise across healthcare, retail, energy, financial services, software, and more, we implement end-to-end solutions to deliver the innovation, quality, and speed that our clients’ users expect.
SoftServe delivers open innovation - from generating compelling new ideas, to developing and implementing transformational products and services. Our work and client experience are built on a foundation of empathetic, human-focused experience design that ensures continuity from concept to release. We empower enterprises and software companies to (re)identify differentiation, accelerate solution development, and vigorously compete in today’s digital economy. No matter where you are in your journey.
Visit our website , blog , LinkedIn , Facebook , and Twitter pages.
View source version on businesswire.com: https://www.businesswire.com/news/home/20211202005018/en/
Link:
Social Media:
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Galderma Provides Progress Update Regarding RelabotulinumtoxinA Regulatory Submission in the United States1.7.2026 07:00:00 CEST | Press release
Galderma received a Complete Response Letter from the FDA with comments related to observations during manufacturing site inspection and analytical method optimization Relfydess is approved in 33 markets and already launched in more than 20, including across Europe, the Middle East and Australia, with an encouraging early launch trajectory supported by positive healthcare professional feedback Regulatory filings in other territories are ongoing and remain on track Ad hoc announcement pursuant to Art. 53 LR Galderma (SIX: GALD) today provided progress updates regarding the regulatory review of its pending Biologics License Application (“BLA”) for RelabotulinumtoxinA with the U.S. Food and Drug Administration (“FDA”). The Company has received a Complete Response Letter (CRL) from the FDA with comments related to observations during manufacturing site inspection and analytical method optimization. As part of its review, the FDA conducted a Pre-License Inspection (PLI) of Galderma’s manufa
EVE Energy Showcases All-Scenario Energy Storage Solutions at The Smarter E Europe 20261.7.2026 03:45:00 CEST | Press release
EVE Energy unveiled its Mr. Big Family series, a 6.9+ MWh energy storage system, and all-scenario energy storage solutions at Intersolar Europe in Munich. Drawing on traceable large-cell technology, proven large-scale energy storage project delivery experience, and global delivery capabilities, the company is addressing Europe's diverse energy storage requirements across utility-scale, commercial & industrial (C&I ), and data center segments. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260630889717/en/ EVE Energy showcases its Mr. Giant 3.0 6.9+ MWh energy storage system at The Smarter E Europe 2026 in Munich, Germany Advancing Large-Cell Technology with Global Project Validation As one of the first companies to focus on large-capacity energy storage cells, EVE Energy has iteratively upgraded its cell platform from 560 Ah and 628 Ah to 702 Ah, adhering to a stacking process route throughout. At the exhibition, the Mr. Gia
Bending Spoons S.p.A. announces pricing of initial public offering1.7.2026 01:56:00 CEST | Press release
Bending Spoons S.p.A. (“Bending Spoons”), a leading technology company, today announces the pricing of its initial public offering (“IPO”) at $29.00 per share. A total of 57,971,015 ordinary shares are being offered, of which 34,398,640 shares are being offered by Bending Spoons and 23,572,375 shares are being offered by certain selling shareholders (the “Selling Shareholders”). Bending Spoons will not receive any proceeds from any sale of shares by the Selling Shareholders. The shares are expected to begin trading on the Nasdaq Global Select Market under the ticker symbol “BSP” on July 1, 2026. The offering is expected to close on July 2, 2026, subject to customary closing conditions. In addition, Bending Spoons and the Selling Shareholders granted the underwriters an option to purchase up to an additional 5,244,026 ordinary shares from Bending Spoons and up to an additional 3,451,626 ordinary shares from the Selling Shareholders at the initial public offering price, less underwriting
FDA Issues Modified Risk Tobacco Product Orders for 20 ZYN Nicotine Pouch Products30.6.2026 18:19:00 CEST | Press release
FDA’s decision makes ZYN the first nicotine pouch product to receive MRTP orders authorizing reduced-risk claims versus cigarettes Philip Morris International Inc. (PMI) (NYSE: PM) today announced that the U.S. Food and Drug Administration (FDA) issued Modified Risk Tobacco Product (MRTP) orders for 20 variants of ZYN nicotine pouch products. These are the first MRTP orders granted for nicotine pouches, allowing PMI U.S. to market the following claim for the authorized ZYN products: “Using ZYN instead of cigarettes puts you at a lower risk of mouth cancer, heart disease, lung cancer, stroke, emphysema, and chronic bronchitis.” “FDA’s decision is an important moment for the more than 45 million legal-age nicotine consumers in America,” saidStacey Kennedy, PMI U.S. CEO. “Today’s news ensures these adultshave access to accurate, science-based information, including FDA-authorized evidence that switching from cigarettes to ZYN reduces the risk of smoking-related diseases like heart disease
Caidya Announces Strategic Combination with Simbec-Orion Bridging Early Scientific Insight and Global Clinical Execution30.6.2026 17:00:00 CEST | Press release
Caidya today announced a strategic combination with Simbec-Orion designed to close the divide between early scientific insight and global clinical execution. The combination of Caidya and Simbec-Orion creates a differentiated specialty clinical CRO platform that enables programs to scale, maintaining focus, speed, and accountability. The strategic combination brings together complementary strengths to create a more complete development partner for innovative biopharma companies. With established operations across Europe, the Americas, APAC, and China, the combined organization provides meaningful expertise and execution capabilities in the regions that matter most. Simbec-Orion brings early-phase clinical pharmacology capabilities alongside deep therapeutic expertise for later stage complex oncology and rare disease trials, helping sponsors shape critical decisions early in the development lifecycle. Together, the organizations strengthen their ability to support complex, cross-border
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom